Changes in histopathological classification of neuroendocrine tumors in 5th edition of WHO classification of gastrointestinal tract tumors (2019)


Authors: Tomáš Jirásek 1;  Václav Mandys 2
Authors‘ workplace: Oddělení patologie, Centrum PATOS, Krajská nemocnice Liberec, a. s. 1;  Ústav patologie 3. LF UK a Fakultní nemocnice Královské Vinohrady, Praha. 2
Published in: Čes.-slov. Patol., 56, 2020, No. 4, p. 207-211
Category: Reviews Article

Overview

In a brief review is presented a summary of news in the classification of neuroendocrine neoplasms of the digestive system, as they were introduced in the 5th edition of the WHO Classification of Digestive System Tumors published in summer 2019.

Keywords:

neuroendocrine neoplasia – NEN – NET – NEC – MiNEN – WHO classification


Sources

1.    Zheng Z, Chen C, Jiang L, et al.  Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: A population-based study. Cancer Med 2019; 8(17): 7288-7298.

2.    Modlin IM, Shapiro MD, Kidd M. Siegfried Oberndorfer: origins and perspectives of carcinoid tumors. Hum Pathol 2004; 35(12): 1440-1451.

3.    Soga J, Tazawa K. Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases. Cancer 1971; 28(4): 990-998.

4.    Solcia E, Klöppel G, Sobin LH. Histological typing of endocrine tumours (2nd edn). Berlin - New York: Springer; 2000: 56-72.

5.    Travis,WD, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart (4th edn). Lyon (France): IARC; 2017: 63-77.

6.    Matěj R, Dundr P, Hornychová H, Ryška A, Tichá I. Nádory plic – doporučený postup pro bioptické vyšetření. Praha: Společnost českých patologů ČLS JEP; 2019: 9-14.

7.    Bordi C, D‘Adda T, Pizzi S, Crafa P, Rindi G. The assessment of malignancy in endocrine tumours of the gastrointestinal tract. Current Diagnostic Pathology 2002; 8(6): 421-429.

8.    Rindi G, Klöppel G. Endocrine tumors of the gut and pancreas tumor biology and classification. Neuroendocrinology 2004; 80 (Suppl 1): 12-15.

9.    Plöckinger U, Rindi G, Arnold R, et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 2004; 80(6): 394-424.

10.  Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO Classification of Tumours of the Digestive system (4th edn). Lyon (France): IARC; 2010: 13-14.

11.  WHO Classification of Tumours Editorial Board. Digestive system tumours (5th edn). Lyon (France): IARC; 2019: 16-19.

12.  Lloyd RV, Osamura RY, Klöppel G, et al. WHO Classification of Tumours of Endocrine Organs (4th edition). Lyon (France): IARC; 2017: 210-239.

13.  Basturk O, Yang Z, Tang LH, et al. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms. Am J Surg Pathol 2015; 39(5): 683-690.

14.  Heetfeld M, Chougnet CN, Olsen IH, et al. Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat Cancer 2015; 22(4): 657-664.

15.  Tang LH, Untch BR, Reidy DL, et al. Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas. Clin Cancer Res 2016; 22(4): 1011-1017.

16.  Esposito I, Segler A, Steiger K, Klöppel G. Pathology, genetics and precursors of human and experimental pancreatic neoplasms: An update. Pancreatology 2015; 15(6): 598-610.

17.  Sipos B, Sperveslage J, Anlauf M, et al. Glucagon cell hyperplasia and neoplasia with and without glucagon receptor mutations. J Clin Endocrinol Metab 2015; 100(5): 783-788.

18.  Noë M, Pea A, Luchini C, et al. Whole-exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1. Mod Pathol 2018; 31(10): 1532-1538.

19.  Iacovazzo D, Flanagan SE, Walker E, et al. MAFA missense mutation causes familial insulinomatosis and diabetes mellitus. Proc Natl Acad Sci U S A 2018; 115(5): 1027-1032.

20.  Fossmark R, Calvete O, Mjønes P, Benitez J, Waldum HL. ECL-cell carcinoids and carcinoma in patients homozygous for an inactivating mutation in the gastric H (+) K (+) ATPase alpha subunit. APMIS 2016; 124(7): 561-566.

Labels
Anatomical pathology Forensic medical examiner Toxicology

Article was published in

Czecho-Slovak Pathology

Issue 4

2020 Issue 4

Most read in this issue
Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account